May 5, 2016 / 9:37 PM / in a year

BRIEF-Cardiome and Allergan announce Xydalba(tm) licensing agreement in international markets

May 5 (Reuters) - Cardiome Pharma Corp

* Additional terms of agreement were not disclosed.

* Cardiome and allergan announce xydalba(tm) (dalbavancin) licensing agreement in international markets

* Expects to initiate commercial sales of xydalba in its territories as early as 2016 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below